Aspirin versus placebo for the treatment of venous leg ulcers—a phase II, pilot, randomised trial (AVURT)
Authors:
- Tilbrook HelenTHTilbrook Helen
- Cook LizCLCook Liz
- Clark LauraCLClark Laura
- Sbizzera IllarySISbizzera Illary
- Bland MartinBMBland Martin
- Buckley HannahBHBuckley Hannah
- Chetter IanCIChetter Ian
- Dumville JoDJDumville Jo
- Fenner ChrisFCFenner Chris
- Forsythe RachaelFRForsythe Rachael
- Gabe RhianGRGabe Rhian
- Harding KeithHKHarding Keith
Open Access
- 26 July 2019
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-10
Abstract
Venous leg ulcers (VLUs) can take many months to heal and 25% fail to heal. The main treatment for venous leg ulcers is compression therapy and few additional therapies exist. Two previous trials indicated that low-dose aspirin may improve healing time, but these trials were insufficiently robust. A multi-centred, pilot, phase II, randomised, double blind, parallel-group, placebo-controlled, efficacy trial (RCT) was conducted to determine: if aspirin improves VLU healing time; the safety of aspirin in this population; treatment compliance; and the feasibility of recruitment to a phase III trial. We recruited patients from secondary care who were aged ≥ 18 years, had a chronic VLU and not regularly taking aspirin. Participants were randomly assigned (1:1) to receive 300 mg of daily aspirin or placebo in addition to standard care, which consisted of multi component compression therapy aiming to deliver 40 mmHg at the ankle where possible. The randomisation list was stratified by ulcer size (≤ 5 cm2 or > 5 cm2). The primary endpoint was time to ulcer healing, which was defined as ‘complete epithelial healing in the absence of scab (eschar) with no dressing required’. Safety outcomes were assessed in all participants who received at least one dose of the study drug. Twenty-seven patients were recruited from eight sites (target 100 patients). A short time-frame to recruit and a large number of patients failing to meet the eligibility criteria were the main barriers to recruitment. There was no evidence of a difference in time to healing of the reference ulcer following adjustment for log ulcer area and duration (hazard ratio 0.58, 95% confidence interval 0.18 to 1.85; p = 0.357). One expected serious adverse event related to aspirin was recorded. A number of options to improve recruitment were explored. There was no evidence that aspirin was effective in expediting the healing of chronic VLUs. However, the analysis was underpowered due to the low number of participants recruited. The trial design would require substantial amendment in order to progress to a phase III (effectiveness) trial. Clinicaltrials.gov, NCT02333123. Registered on 5 November 2014.Keywords
Funding Information
- Health Technology Assessment Programme (13/87/08, 13/87/08)
This publication has 18 references indexed in Scilit:
- Guided, internet-based, rumination-focused cognitive behavioural therapy (i-RFCBT) versus a no-intervention control to prevent depression in high-ruminating young adults, along with an adjunct assessment of the feasibility of unguided i-RFCBT, in the REducing Stress and Preventing Depression trial (RESPOND): study protocol for a phase III randomised controlled trialTrials, 2016
- Low-dose aspirin as an adjuvant treatment for venous leg ulceration: study protocol for a randomized controlled trial (Aspirin4VLU)Journal of Advanced Nursing, 2015
- Aspirin for Venous Ulcers: Randomised Trial (AVURT): study protocol for a randomised controlled trialTrials, 2015
- Lessons learned from recruiting socioeconomically disadvantaged smokers into a pilot randomized controlled trial to explore the role of Exercise Assisted Reduction then Stop (EARS) smokingTrials, 2015
- Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trialThe Lancet, 2014
- Influence of Aspirin Therapy in the Ulcer Associated With Chronic Venous InsufficiencyAnnals of Vascular Surgery, 2012
- Aspirin Dose for the Prevention of Cardiovascular DiseaseJAMA, 2007
- The mechanism of action of aspirinThrombosis Research, 2003
- Chronic venous insufficiency and venous leg ulcerationJournal of the American Academy of Dermatology, 2001
- Randomised trial of oral aspirin for chronic venous leg ulcersThe Lancet, 1994